Tags

Type your tag names separated by a space and hit enter

Polycystic ovarian syndrome in adolescence.
Gynecol Endocrinol. 2009 Oct; 25(10):634-9.GE

Abstract

BACKGROUND

Polycystic ovarian syndrome (PCOS), which is a common endocrinopathy seen not only in adult women but also in female adolescents nowadays, is associated with reproductive, metabolic and cardiovascular problems.

OBJECTIVE

This article aims to review the current evidence on managing PCOS in adolescence. In addition, the pathophysiology, risk factors, clinical presentations and existing diagnostic criteria of PCOS will also be discussed.

DISCUSSION

Certain risk factors are available to assist the clinicians to identify adolescents at risk of PCOS as the signs can be masked by the normal physiological changes during puberty. It is important to screen and diagnose adolescent PCOS in order to prevent the development of future infertility, type II diabetes mellitus, cardiovascular disease, and even endometrial cancer. Lifestyle modification is of the greatest benefit for adolescents in terms of management, with the condition that full support is available from both the clinicians and their families. The psychological impact of PCOS also constitutes a major concern in adolescent PCOS.

Authors+Show Affiliations

University of New South Wales, Sydney, Australia.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

19533479

Citation

Yii, Ming Fong, et al. "Polycystic Ovarian Syndrome in Adolescence." Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, vol. 25, no. 10, 2009, pp. 634-9.
Yii MF, Lim CE, Luo X, et al. Polycystic ovarian syndrome in adolescence. Gynecol Endocrinol. 2009;25(10):634-9.
Yii, M. F., Lim, C. E., Luo, X., Wong, W. S., Cheng, N. C., & Zhan, X. (2009). Polycystic ovarian syndrome in adolescence. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 25(10), 634-9. https://doi.org/10.1080/09513590903015551
Yii MF, et al. Polycystic Ovarian Syndrome in Adolescence. Gynecol Endocrinol. 2009;25(10):634-9. PubMed PMID: 19533479.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Polycystic ovarian syndrome in adolescence. AU - Yii,Ming Fong, AU - Lim,Chi Eung Danforn, AU - Luo,Xiping, AU - Wong,Wu Shun Felix, AU - Cheng,Nga Chong Lisa, AU - Zhan,Xinlin, PY - 2009/6/18/entrez PY - 2009/6/18/pubmed PY - 2010/1/27/medline SP - 634 EP - 9 JF - Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology JO - Gynecol Endocrinol VL - 25 IS - 10 N2 - BACKGROUND: Polycystic ovarian syndrome (PCOS), which is a common endocrinopathy seen not only in adult women but also in female adolescents nowadays, is associated with reproductive, metabolic and cardiovascular problems. OBJECTIVE: This article aims to review the current evidence on managing PCOS in adolescence. In addition, the pathophysiology, risk factors, clinical presentations and existing diagnostic criteria of PCOS will also be discussed. DISCUSSION: Certain risk factors are available to assist the clinicians to identify adolescents at risk of PCOS as the signs can be masked by the normal physiological changes during puberty. It is important to screen and diagnose adolescent PCOS in order to prevent the development of future infertility, type II diabetes mellitus, cardiovascular disease, and even endometrial cancer. Lifestyle modification is of the greatest benefit for adolescents in terms of management, with the condition that full support is available from both the clinicians and their families. The psychological impact of PCOS also constitutes a major concern in adolescent PCOS. SN - 1473-0766 UR - https://www.unboundmedicine.com/medline/citation/19533479/Polycystic_ovarian_syndrome_in_adolescence_ L2 - https://www.tandfonline.com/doi/full/10.1080/09513590903015551 DB - PRIME DP - Unbound Medicine ER -